Evaluation of Reference variability [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2010-03-16 17:01 (5576 d 03:08 ago) – Posting: # 4921
Views: 3,821

Dear Marcel!

❝ My apologies for dragging this replicate skeleton out of the closet when it seemed like it was comfortably resting.


No problem - if you think we need some more forensics, go for exhumation!

❝ Was there any mention at this meeting as to whether the results of a replicate design study (finding of intra-subject variablility exceeding 30%) with a lower strength can be used to justify widen acceptance limits for a higher strength of the same drug to undergo a standard BE study?


No. Or to be more precise, nobody asked that question, but I would bet the answer would have been a straight "No!" as well.

❝ If this is not allowed, can someone explain why not?


I would say there are two reasons.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
54 visitors (0 registered, 54 guests [including 11 identified bots]).
Forum time: 21:10 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5